These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37669834)

  • 1. Haptoglobin is an independent marker for disease severity and risk for metabolic complications in hidradenitis suppurativa: A prospective study.
    Abu Rached N; Gambichler T; Ocker L; Skrygan M; Seifert C; Scheel CH; Stockfleth E; Bechara FG
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):205-213. PubMed ID: 37669834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS).
    Hessam S; Sand M; Gambichler T; Bechara FG
    J Am Acad Dermatol; 2015 Dec; 73(6):998-1005. PubMed ID: 26410359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa-A Monocentric Study in Germany.
    Abu Rached N; Gambichler T; Ocker L; Dietrich JW; Quast DR; Sieger C; Seifert C; Scheel C; Bechara FG
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of the refined Hurley classification for hidradenitis suppurativa with patient-reported quality of life and objective disease severity assessment.
    Rondags A; van Straalen KR; van Hasselt JR; Janse IC; Ardon CB; Vossen ARJV; Prens EP; van der Zee HH; Horváth B
    Br J Dermatol; 2019 May; 180(5):1214-1220. PubMed ID: 30512186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa.
    Akdogan N; Dogan S; Incel-Uysal P; Karabulut E; Topcuoglu C; Yalcin B; Atakan N
    Arch Dermatol Res; 2020 May; 312(4):255-262. PubMed ID: 31729595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa.
    Hessam S; Scholl L; Sand M; Schmitz L; Reitenbach S; Bechara FG
    JAMA Dermatol; 2018 Mar; 154(3):330-335. PubMed ID: 29417136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Immunoglobulin G Is a Marker of Hidradenitis Suppurativa Disease Severity.
    Mintoff D; Borg I; Pace NP
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors Associated with Severe Hidradenitis Suppurativa, Using Hurley Staging and Metascore.
    Daoud M; Suppa M; Benhadou F; Heudens S; Sarkis AS; Njimi H; Saunte SK; Desmarest L; Orte Cano C; Dandoy C; Nobile L; Fontaine M; Daxhelet M; Karama J; White JM; Jemec GBE; Del Marmol V
    Dermatology; 2024; 240(5-6):713-731. PubMed ID: 39396514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview and comparison of the clinical scores in hidradenitis suppurativa: A real-life clinical data.
    Daoud M; Suppa M; Benhadou F; Daxhelet M; Njimi H; White J; Jemec G; Del Marmol V
    Front Med (Lausanne); 2023; 10():1145152. PubMed ID: 37138732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa.
    Gambichler T; Hessam S; Cramer P; Abu Rached N; Bechara FG
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1593-1596. PubMed ID: 35462426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S2k guideline for the treatment of hidradenitis suppurativa / acne inversa - Short version.
    Zouboulis CC; Bechara FG; Fritz K; Goebeler M; Hetzer FH; Just E; Kirsten N; Kokolakis G; Kurzen H; Nikolakis G; Pinter A; Podda M; Rosinski K; Schneider-Burrus S; Taube KM; Volz T; Winkler T; Kristandt A; Presser D; Zouboulis VA
    J Dtsch Dermatol Ges; 2024 Jun; 22(6):868-889. PubMed ID: 38770982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity.
    Zouboulis CC; Tzellos T; Kyrgidis A; Jemec GBE; Bechara FG; Giamarellos-Bourboulis EJ; Ingram JR; Kanni T; Karagiannidis I; Martorell A; Matusiak Ł; Pinter A; Prens EP; Presser D; Schneider-Burrus S; von Stebut E; Szepietowski JC; van der Zee HH; Wilden SM; Sabat R;
    Br J Dermatol; 2017 Nov; 177(5):1401-1409. PubMed ID: 28636793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline Characteristics from UNITE: An Observational, International, Multicentre Registry to Evaluate Hidradenitis Suppurativa (Acne Inversa) in Clinical Practice.
    Prens EP; Lugo-Somolinos AM; Paller AS; Kerdel F; Duan Y; Teixeira HD; Longcore M; Kimball AB
    Am J Clin Dermatol; 2020 Aug; 21(4):579-590. PubMed ID: 32077014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial fat thickness is ıncreased and associated with disease severity in hidradenitis suppurativa.
    Alatas ET; Biteker M; Alatas OD
    Arch Dermatol Res; 2020 Sep; 312(7):467-472. PubMed ID: 31894390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low-calorie ketogenic diet (VLCKD) in the management of hidradenitis suppurativa (Acne Inversa): an effective and safe tool for improvement of the clinical severity of disease. Results of a pilot study.
    Verde L; Cacciapuoti S; Caiazzo G; Megna M; Martora F; Cavaliere A; Mattera M; Maisto M; Tenore GC; Colao A; Savastano S; Muscogiuri G; Barrea L
    J Transl Med; 2024 Feb; 22(1):149. PubMed ID: 38350939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could Residents Adequately Assess the Severity of Hidradenitis Suppurativa? Interrater and Intrarater Reliability Assessment of Major Scoring Systems.
    Włodarek K; Stefaniak A; Matusiak Ł; Szepietowski JC
    Dermatology; 2020; 236(1):8-14. PubMed ID: 31487719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Wave Medical Infrared Thermography: A Clinical Biomarker of Inflammation in Hidradenitis Suppurativa/Acne Inversa.
    Zouboulis CC; Nogueira da Costa A; Jemec GBE; Trebing D
    Dermatology; 2019; 235(2):144-149. PubMed ID: 30650424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of serum amyloid A, interleukin-6 and C-reactive protein correlate with severity of hidradenitis suppurativa.
    Srour J; Marsela E; Fiocco Z; Kendziora B; Gürtler A; French LE; Reinholz M
    Ital J Dermatol Venerol; 2023 Aug; 158(4):341-346. PubMed ID: 37404192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.